Berberine Ameliorates Collagen-Induced Arthritis in Rats Associated with Anti-inflammatory and Anti-angiogenic Effects

Inflammation

Volumn 37, Issue 5, 2014, Pages 1789-1798

  Wang, Zhigang ^a   Chen, Zhe ^b   Yang, Sisi ^b   Wang, Yu ^b   Huang, Zhaoyi ^b   Gao, Jianfei ^a   Tu, Shenghao ^b   Rao, Zhiguo ^a  

^a WUHAN GENERAL HOSPITAL OF GUANGZHOU COMMAND   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

anti angiogenic effect; anti inflammatory effect; berberine; collagen induced arthritis; vascular endothelial growth factor

Indexed keywords

BERBERINE; CD34 ANTIGEN; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; ANGIOGENESIS INHIBITOR; ANTIINFLAMMATORY AGENT; COLLAGEN TYPE 2;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; CAPILLARY DENSITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; FEMALE; IMMUNOHISTOCHEMISTRY; NONHUMAN; PROTEIN EXPRESSION; RAT; RHEUMATOID ARTHRITIS; WESTERN BLOTTING; ANIMAL; ARTHRITIS, EXPERIMENTAL; BOVINE; CHEMICALLY INDUCED; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALIA; BOVINAE; RATTUS;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, EXPERIMENTAL; BERBERINE; CATTLE; COLLAGEN TYPE II; FEMALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84918832922     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-014-9909-y     Document Type: Article

References (42)

1. Parolini, O., L. Souza-Moreira, F. O'Valle, M. Magatti, P. Hernandez-Cortes, E. Gonzalez-Rey, et al. 2014. Therapeutic effect of human amniotic membrane-derived cells on experimental arthritis and other inflammatory disorders. Arthritis and Rheumatism 66: 327–339.
2. Bombardier, C., M. Barbieri, A. Parthan, D.J. Zack, V. Walker, D. Macarios, et al. 2012. The relationship between joint damage and functional disability in rheumatoid arthritis: a systematic review. Annals of the Rheumatic Diseases 71: 836–844.
3. Moreland, L.W., and J.R. Curtis. 2009. Systemic nonarticular manifestations of rheumatoid arthritis: focus on inflammatory mechanisms. Seminars in Arthritis and Rheumatism 39: 132–143.
4. Miller, A.M., and I.B. McInnes. 2011. Cytokines as therapeutic targets to reduce cardiovascular risk in chronic inflammation. Current Pharmaceutical Design 17: 1–8.
5. Schroeder, M., L. Viezens, I. Fuhrhop, W. Rüther, C. Schaefer, B. Schwarzloh, et al. 2013. Angiogenic growth factors in rheumatoid arthritis. Rheumatology International 33: 523–527.
6. Semerano, L., E. Duvallet, N. Belmellat, N. Schall, M. Monteil, A. Starzec, et al. 2014. A1.36 Active immunisation against peptides of VEGF improves joint inflammation and destruction in collagen-induced arthritis. Annals of the Rheumatic Diseases 73(Suppl 1): A15–A16.
7. Marrelli, A., P. Cipriani, V. Liakouli, F. Carubbi, C. Perricone, R. Perricone, et al. 2011. Angiogenesis in rheumatoid arthritis: a disease specific process or a common response to chronic inflammation? Autoimmunity Reviews 10: 595–598.
8. Szekanecz, Z., and A.E. Koch. 2008. Targeting angiogenesis in rheumatoid arthritis. Current Rheumatology Reviews 4: 298–303.
9. Kong, W., J. Wei, P. Abidi, M. Lin, S. Inaba, C. Li, et al. 2004. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nature Medicine 10: 1344–1351.
10. Qin, X., B.T. Guo, B. Wan, L. Fang, L. Lu, L. Wu, et al. 2010. Regulation of Th1 and Th17 cell differentiation and amelioration of experimental autoimmune encephalomyelitis by natural product compound berberine. Journal of Immunology 185: 1855–1863.
11. Kuo, C.L., C.W. Chi, and T.Y. Liu. 2004. The anti-inflammatory potential of berberine in vitro and in vivo. Cancer Letters 203: 127–137.
12. Yang, X., and N. Huang. 2013. Berberine induces selective apoptosis through the AMPK-mediated mitochondrial/caspase pathway in hepatocellular carcinoma. Molecular Medicine Reports 8: 505–510.
13. Remmers, E.F., B. Joe, M.M. Griffiths, D.E. Dobbins, S.V. Dracheva, A. Hashiramoto, et al. 2002. Modulation of multiple experimental arthritis models by collagen-induced arthritis quantitative trait loci isolated in congenic rat lines: different effects of non-major histocompatibility complex quantitative trait loci in males and females. Arthritis and Rheumatism 46: 2225–2234.
14. Rosloniec, E.F., M. Cremer, A. Kang, and L.K. Myers. 2001. Collagen-induced arthritis. Curr Protoc Immunol Chapter 15: Unit 15.5.
15. Weidner, N. 1995. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Research and Treatment 36: 169–180.
16. Sun, Y., K. Xun, Y. Wang, and X. Chen. 2009. A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs. Anti-Cancer Drugs 20: 757–769.
17. Brennan, F.M., and I.B. McInnes. 2008. Evidence that cytokines play a role in rheumatoid arthritis. Journal of Clinical Investigation 118: 3537–3545.
18. Bertolini, D.R., G.E. Nedwin, T.S. Bringman, D.D. Smith, and G.R. Mundy. 1986. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature 319: 516–518.
19. van Leeuwen, M.A., J. Westra, P.C. Limburg, P.L. van Riel, and M.H. van Rijswijk. 1995. Interleukin-6 in relation to other proinflammatory cytokines, chemotactic activity and neutrophil activation in rheumatoid synovial fluid. Annals of the Rheumatic Diseases 54: 33–38.
20. Tak, P.P., and B. Bresnihan. 2000. The pathogenesis and prevention of joint damage in rheumatoid arthritis: advances from synovial biopsy and tissue analysis. Arthritis and Rheumatism 43: 2619–2633.
21. Ying, X., X. Chen, S. Cheng, Z. Zhao, X. Guo, H. Chen, et al. 2013. SeMet inhibits IL-1β-induced rheumatoid fibroblast-like synoviocytes proliferation and the production of inflammatory mediators. Biological Trace Element Research 153: 437–445.
22. Benedetti, G., and P. Miossec. 2014. Interleukin 17 contributes to the chronicity of inflammatory diseases such as rheumatoid arthritis. European Journal of Immunology 44: 339–347.
23. Azizi, G., F. Jadidi-Niaragh, and A. Mirshafiey. 2013. Th17 Cells in immunopathogenesis and treatment of rheumatoid arthritis. International Journal of Rheumatic Diseases 16: 243–253.
24. Park, M.J., H.S. Park, H.J. Oh, J.Y. Lim, B.Y. Yoon, H.Y. Kim, et al. 2012. IL-17-deficient allogeneic bone marrow transplantation prevents the induction of collagen-induced arthritis in DBA/1J mice. Experimental and Molecular Medicine 44: 694–705.
25. Isozaki, T., J.H. Ruth, M.A. Amin, P.L. Campbell, P.S. Tsou, C.M. Ha, et al. 2014. Fucosyltransferase 1 mediates angiogenesis, cell adhesion and rheumatoid arthritis synovial tissue fibroblast proliferation. Arthritis Research and Therapy 16: R28.
26. Thairu, N., S. Kiriakidis, P. Dawson, and E. Paleolog. 2011. Angiogenesis as a therapeutic target in arthritis in 2011: learning the lessons of the colorectal cancer experience. Angiogenesis 14: 223–234.
27. Kong, X., Y. Zhang, C. Liu, W. Guo, X. Li, X. Su, et al. 2013. Anti-angiogenic effect of triptolide in rheumatoid arthritis by targeting angiogenic cascade. PLoS One 8: e77513.
28. Vordenbäumen, S., P. Sewerin, T. Lögters, F. Miese, C. Schleich, E. Bleck, et al. 2014. Inflammation and vascularisation markers of arthroscopically guided finger joint synovial biopsies reflect global disease activity in rheumatoid arthritis. Clinical and Experimental Rheumatology 32: 117–120.
29. Yoo, S.A., S.K. Kwok, and W.U. Kim. 2008. Proinflammatory role of vascular endothelial growth factor in the pathogenesis of rheumatoid arthritis: prospects for therapeutic intervention. Mediators of Inflammation 2008: 129873.
30. Yoo, S.A., D.G. Bae, J.W. Ryoo, H.R. Kim, G.S. Park, C.S. Cho, et al. 2005. Arginine-rich anti-vascular endothelial growth factor (anti-VEGF) hexapeptide inhibits collagen-induced arthritis and VEGF-stimulated productions of TNF-alpha and IL-6 by human monocytes. Journal of Immunology 174: 5846–5855.
31. Cho, C.S., M.L. Cho, S.Y. Min, W.U. Kim, D.J. Min, S.S. Lee, et al. 2000. CD40 engagement on synovial fibroblast up-regulates production of vascular endothelial growth factor. Journal of Immunology 164: 5055–5061.
32. Kasama, T., F. Shiozawa, K. Kobayashi, N. Yajima, M. Hanyuda, H.T. Takeuchi, et al. 2001. Vascular endothelial growth factor expression by activated synovial leukocytes in rheumatoid arthritis: critical involvement of the interaction with synovial fibroblasts. Arthritis and Rheumatism 44: 2512–2524.
33. Mould, A.W., I.D. Tonks, M.M. Cahill, A.R. Pettit, R. Thomas, N.K. Hayward, et al. 2003. Vegfb gene knockout mice display reduced pathology and synovial angiogenesis in both antigen-induced and collagen-induced models of arthritis. Arthritis and Rheumatism 48: 2660–2669.
34. Ferrara, N., H.P. Gerber, and J. LeCouter. 2003. The biology of VEGF and its receptors. Nature Medicine 9: 669–676.
35. Oura, H., J. Bertoncini, P. Velasco, L.F. Brown, P. Carmeliet, and M. Detmar. 2003. A critical role of placental growth factor in the induction of inflammation and edema formation. Blood 101: 560–567.
36. Kong, J.S., S.A. Yoo, J.W. Kim, S.P. Yang, C.B. Chae, V. Tarallo, et al. 2010. Anti-neuropilin-1 peptide inhibition of synoviocyte survival, angiogenesis, and experimental arthritis. Arthritis and Rheumatism 62: 179–190.
37. Rabquer, B.J., and A.E. Koch. 2013. NK4 therapy: a new approach to target angiogenesis and inflammation in rheumatoid arthritis. Arthritis Research and Therapy 15: 119.
38. Chen, Z., S. Tu, Y. Hu, Y. Wang, Y. Xia, and Y. Jiang. 2012. Prediction of response of collagen-induced arthritis rats to methotrexate: an (1)H-NMR-based urine metabolomic analysis. Journal of Huazhong University of Science and Technology. Medical Sciences 32: 438–443.
39. Tang, X., Y. Yang, H. Yuan, J. You, M. Burkatovskaya, and S. Amar. 2013. Novel transcriptional regulation of VEGF in inflammatory processes. Journal of Cellular and Molecular Medicine 17: 386–397.
40. Kong, X., C. Liu, C. Zhang, J. Zhao, J. Wang, H. Wan, et al. 2013. The suppressive effects of Saposhnikovia divaricata (Fangfeng) chromone extract on rheumatoid arthritis via inhibition of nuclear factor-κB and mitogen activated protein kinases activation on collagen-induced arthritis model. Journal of Ethnopharmacology 148: 842–850.
41. Jia, L., J. Liu, Z. Song, X. Pan, L. Chen, X. Cui, et al. 2012. Berberine suppresses amyloid-beta-induced inflammatory response in microglia by inhibiting nuclear factor-kappaB and mitogen-activated protein kinase signalling pathways. Journal of Pharmacy and Pharmacology 64: 1510–1521.
42. Jeong, H.W., K.C. Hsu, J.W. Lee, M. Ham, J.Y. Huh, H.J. Shin, et al. 2009. Berberine suppresses proinflammatory responses through AMPK activation in macrophages. American Journal of Physiology - Endocrinology and Metabolism 296: E955–E964.